Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
<h4>Background/objective</h4>Weight loss is a predictor of shorter survival in amyotrophic lateral sclerosis (ALS). We performed serial measures of body composition using Dual-energy X-ray Absorptiometry (DEXA) in ALS patients to explore its utility as a biomarker of disease progression....
        Saved in:
      
    
                  | Main Authors: | Ikjae Lee, Mohamed Kazamel, Tarrant McPherson, Jeremy McAdam, Marcas Bamman, Amy Amara, Daniel L Smith, Peter H King | 
|---|---|
| Format: | article | 
| Language: | EN | 
| Published: | 
        
      Public Library of Science (PLoS)    
    
      2021
     | 
| Subjects: | |
| Online Access: | https://doaj.org/article/cbf11b03b4c740548528a386c9a157d3 | 
| Tags: | 
       Add Tag    
     
      No Tags, Be the first to tag this record!
   
 | 
Similar Items
- 
                
        
          Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis        
                  
by: Thaddaeus Kwan, et al.
Published: (2020) - 
                
        
          Amyotrophic lateral sclerosis and frontotemporal degeneration        
                          
Published: (2000) - 
                
        
          The cortical signature of amyotrophic lateral sclerosis.        
                  
by: Federica Agosta, et al.
Published: (2012) - 
                
        
          Abnormal RNA stability in amyotrophic lateral sclerosis        
                  
by: E. M. Tank, et al.
Published: (2018) - 
                
        
          Current and emerging treatments for amyotrophic lateral sclerosis        
                  
by: Stefano Zoccolella, et al.
Published: (2009)